Dose-dependent effects of experimental infection with the virulent Neospora caninum Nc-Spain7 isolate in a pregnant mouse model

Veterinary Parasitology

Volumn 211, Issue 3-4, 2015, Pages 133-140

  Arranz Solís, David ^a   Aguado Martínez, Adriana ^b   Müller, Joachim ^b   Regidor Cerrillo, Javier ^a   Ortega Mora, Luis Miguel ^a   Hemphill, Andrew ^b  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Dose titration; Experimental infection; Nc spain7; Neospora caninum; Neosporosis; Pregnant mouse model

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; EXPERIMENTAL INFECTION; FEMALE; HUMORAL IMMUNITY; IN VIVO STUDY; LITTER SIZE; MORBIDITY; MORTALITY; MOUSE; MOUSE MODEL; NEOSPOROSIS; NONHUMAN; PARASITE ISOLATION; PARASITE LOAD; PARASITE VIRULENCE; PREGNANCY RATE; SURVIVAL RATE; TACHYZOITE; VERTICAL TRANSMISSION; ANIMAL; ANTIBODY SPECIFICITY; BAGG ALBINO MOUSE; BLOOD; BRAIN; CLASSIFICATION; COCCIDIOSIS; DISEASE MODEL; IMMUNOLOGY; ISOLATION AND PURIFICATION; NEOSPORA; PARASITOLOGY; PATHOGENICITY; PATHOLOGY; PREGNANCY; SKIN; VIRULENCE;

MUS; NEOSPORA CANINUM; OVIS ARIES;

IMMUNOGLOBULIN G; PROTOZOAL DNA; PROTOZOON ANTIBODY;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIBODY SPECIFICITY; BRAIN; COCCIDIOSIS; DISEASE MODELS, ANIMAL; DNA, PROTOZOAN; FEMALE; IMMUNOGLOBULIN G; LITTER SIZE; MICE; MICE, INBRED BALB C; NEOSPORA; PREGNANCY; SKIN; VIRULENCE;

EID: 84938286619     PISSN: 03044017     EISSN: 18732550     Source Type: Journal    
DOI: 10.1016/j.vetpar.2015.05.021     Document Type: Article

References (43)

1. Aguado-Martínez A., Álvarez-García G., Fernández-García A., Risco-Castillo V., Marugán-Hernández V., Ortega-Mora L.M. Failure of a vaccine using immunogenic recombinant proteins rNcSAG4 and rNcGRA7 against neosporosis in mice. Vaccine 2009, 27(52):7331-7338.
2. Álvarez-García G., Pereira-Bueno J., Gómez-Bautista M., Ortega-Mora L.M. Pattern of recognition of Neospora caninum tachyzoite antigens by naturally infected pregnant cattle and aborted foetuses. Vet. Parasitol. 2002, 107(1-2):15-27.
3. Arranz-Solís D., Benavides J., Regidor-Cerrillo J., Fuertes M., Ferre I., Ferreras M.C., Collantes-Fernández E., Hemphill A., Pérez V., Ortega-Mora L.M. Influence of the gestational stage on the clinical course, lesional development and parasite distribution in experimental ovine neosporosis. Vet. Res. 2015, 46(1):19.
4. Bartley P.M., Wright S., Sales J., Chianini F., Buxton D., Innes E.A. Long-term passage of tachyzoites in tissue culture can attenuate virulence of Neospora caninum in vivo. Parasitology 2006, 133:421-432.
5. Benavides J., Collantes-Fernández E., Ferre I., Pérez V., Campero C., Mota R., Innes E., Ortega-Mora L.M. Experimental ruminant models for bovine neosporosis: what is known and what is needed. Parasitology 2014, 141(11):1471-1488.
6. Bland J.M., Altman D.G. The logrank test. BMJ 2004, 328(7447):1073.
7. Bland J.M., Altman D.G. Survival probabilities (the kaplan-meier method). BMJ 1998, 317(7172):1572.
8. Caspe S.G., Moore D.P., Leunda M.R., Cano D.B., Lischinsky L., Regidor-Cerrillo J., Álvarez-García G., Echaide I.G., Bacigalupe D., Ortega Mora L.M., Odeon A.C., Campero C.M. The Neospora caninum-spain 7 isolate induces placental damage, fetal death and abortion in cattle when inoculated in early gestation. Vet. Parasitol. 2012, 189(2-4):171-181.
9. Collantes-Fernández E., Arrighi R.B., Álvarez-García G., Weidner J.M., Regidor-Cerrillo J., Boothroyd J.C., Ortega-Mora L.M., Barragán A. Infected dendritic cells facilitate systemic dissemination and transplacental passage of the obligate intracellular parasite Neospora caninum in mice. PLoS One 2012, 7(3):e32123.
10. Collantes-Fernández E., López-Pérez I., Álvarez-García G., Ortega-Mora L.M. Temporal distribution and parasite load kinetics in blood and tissues during Neospora caninum infection in mice. Infect. Immun. 2006, 74(4):2491-2494.
11. Debache K., Alaeddine F., Guionaud C., Monney T., Müller J., Strohbusch M., Leib S.L., Grandgirard D., Hemphill A. Vaccination with recombinant NcROP2 combined with recombinant ncmic1 and ncmic3 reduces cerebral infection and vertical transmission in mice experimentally infected with Neospora caninum tachyzoites. Int. J. Parasitol. 2009, 39(12):1373-1384.
12. Debache K., Guionaud C., Kropf C., Boykin D., Stephens C.E., Hemphill A. Experimental treatment of Neospora caninum-infected mice with the arylimidamide db750 and the thiazolide nitazoxanide. Exp. Parasitol. 2011, 129(2):95-100.
13. Debache K., Hemphill A. Effects of miltefosine treatment in fibroblast cell cultures and in mice experimentally infected with Neospora caninum tachyzoites. Parasitology 2012, 139(7):934-9441.
14. Dellarupe A., Regidor-Cerrillo J., Jiménez-Ruiz E., Schares G., Unzaga J.M., Venturini M.C., Ortega-Mora L.M. Clinical outcome and vertical transmission variability among canine Neospora caninum isolates in a pregnant mouse model of infection. Parasitology 2014, 141(3):356-366.
15. Dubey J.P., Jenkins M.C., Rajendran C., Miska K., Ferreira L.R., Martins J., Kwok O.C., Choudhary S. Gray wolf (Canis lupus) is a natural definitive host for Neospora caninum. Vet. Parasitol. 2011, 181(2-4):382-387.
16. Dubey J.P., Schares G. Neosporosis in animals - the last five years. Vet. Parasitol. 2011, 180(1-2):90-108.
17. Dubey J.P., Schares G., Ortega-Mora L.M. Epidemiology and control of neosporosis and Neospora caninum. Clin. Microbiol. Rev. 2007, 20(2):323-367.
18. Liddell S., Jenkins M.C., Collica C.M., Dubey J.P. Prevention of vertical transfer of Neospora caninum in BALB/c mice by vaccination. J. Parasitol. 1999, 85(6):1072-1075.
19. Long M.T., Baszler T.V., Mathison B.A. Comparison of intracerebral parasite load, lesion development, and systemic cytokines in mouse strains infected with Neospora caninum. J. Parasitol. 1998, 84(2):316-320.
20. López-Pérez I.C., Collantes-Fernández E., Aguado-Martínez A., Rodríguez-Bertos A., Ortega-Mora L.M. Influence of Neospora caninum infection in balb/c mice during pregnancy in post-natal development. Vet. Parasitol. 2008, 155(3-4):175-183.
21. López-Pérez I.C., Collantes-Fernández E., Rojo-Montejo S., Navarro-Lozano V., Risco-Castillo V., Pérez-Pérez V., Pereira-Bueno J., Ortega-Mora L.M. Effects of Neospora caninum infection at mid-gestation on placenta in a pregnant mouse model. J. Parasitol. 2010, 96(5):1017-1020.
22. López-Pérez I.C., Risco-Castillo V., Collantes-Fernández E., Ortega-Mora L.M. Comparative effect of Neospora caninum infection in BALB/c mice at three different gestation periods. J. Parasitol. 2006, 92(6):1286-1291.
23. Lundén A., Wright S., Allen J.E., Buxton D. Immunisation of mice against neosporosis. Int. J. Parasitol. 2002, 32(7):867-876.
24. Marugán-Hernández V., Ortega-Mora L.M., Aguado-Martínez A., Jimenez-Ruiz E., Álvarez-García G. Transgenic Neospora caninum strains constitutively expressing the bradyzoite ncsag4 protein proved to be safe and conferred significant levels of protection against vertical transmission when used as live vaccines in mice. Vaccine 2011, 29(44):7867-7874.
25. McAllister M.M., Dubey J.P., Lindsay D.S., Jolley W.R., Wills R.A., McGuire A.M. Dogs are definitive hosts of Neospora caninum. Int. J. Parasitol. 1998, 28(9):1473-1478.
26. Monney T., Debache K., Grandgirard D., Leib S.L., Hemphill A. Vaccination with the recombinant chimeric antigen recNcMIC3-1-R induces a non-protective Th2-type immune response in the pregnant mouse model for N. caninum infection. Vaccine 2012, 30(46):6588-6594.
27. Monney T., Hemphill A. Vaccines against neosporosis: what can we learn from the past studies?. Exp. Parasitol. 2014, 140:52-70.
28. Monney T., Rutti D., Schorer M., Debache K., Grandgirard D., Leib S.L., Hemphill A. Recncmic3-1-r is a microneme- and rhoptry-based chimeric antigen that protects against acute neosporosis and limits cerebral parasite load in the mouse model for Neospora caninum infection. Vaccine 2011, 29(40):6967-6975.
29. Müller N., Vonlaufen N., Gianinazzi C., Leib S.L., Hemphill A. Application of real-time fluorescent pcr for quantitative assessment of Neospora caninum infections in organotypic slice cultures of rat central nervous system tissue. J. Clin. Microbiol. 2002, 40(1):252-255.
30. Naguleswaran A., Muller N., Hemphill A. Neospora caninum and toxoplasma gondii: a novel adhesion/invasion assay reveals distinct differences in tachyzoite-host cell interactions. Exp. Parasitol. 2003, 104(3-4):149-158.
31. Nishikawa Y., Tragoolpua K., Inoue N., Makala L., Nagasawa H., Otsuka H., Mikami T. In the absence of endogenous gamma interferon, mice acutely infected with Neospora caninum succumb to a lethal immune response characterized by inactivation of peritoneal macrophages. Clin. Diagn. Lab. Immunol. 2001, 8(1071-412; 4):811-816.
32. Ojo K.K., Reid M.C., Kallur Siddaramaiah L., Müller J., Winzer P., Zhang Z., Keyloun K.R., Vidadala R.S., Merritt E.A., Hol W.G., Maly D.J., Fan E., Van Voorhis W.C., Hemphill A. Neospora caninum calcium-dependent protein kinase 1 is an effective drug target for neosporosis therapy. PLoS One 2014, 9(3):e92929.
33. Pastor-Fernández I., Arranz-Solís D., Regidor-Cerrillo J., Álvarez-García G., Hemphill A., García-Culebras A., Cuevas-Martín C., Ortega-Mora L.M. A vaccine formulation combining rhoptry proteins NcROP40 and NcROP2 improves pup survival in a pregnant mouse model of neosporosis. Vet. Parasitol. 2015, 207(3-4):203-215.
34. Regidor-Cerrillo J., Arranz-Solís D., Benavides J., Gómez-Bautista M., Castro-Hermida J.A., Mezo M., Perez V., Ortega-Mora L.M., González-Warleta M. Neospora caninum infection during early pregnancy in cattle: how the isolate influences infection dynamics, clinical outcome and peripheral and local immune responses. Vet. Res. 2014, 45(10):9716.
35. Regidor-Cerrillo J., Gómez-Bautista M., Del Pozo I., Jiménez-Ruiz E., Aduriz G., Ortega-Mora L.M. Influence of neospora caninum intra-specific variability in the outcome of infection in a pregnant BALB/c mouse model. Vet. Res. 2010, 41(4):52.
36. Regidor-Cerrillo J., Gómez-Bautista M., Pereira-Bueno J., Aduriz G., Navarro-Lozano V., Risco-Castillo V., Fernández-García A., Pedraza-Díaz S., Ortega-Mora L.M. Isolation and genetic characterization of Neospora caninum from asymptomatic calves in spain. Parasitology 2008, 135(14):1651-1659.
37. Regidor-Cerrillo J., Gómez-Bautista M., Sodupe I., Aduriz G., Álvarez-García G., Del Pozo I., Ortega-Mora L.M. In vitro invasion efficiency and intracellular proliferation rate comprise virulence-related phenotypic traits of Neospora caninum. Vet. Res. 2011, 42(1):41.
38. Reichel M.P., Alejandra Ayanegui-Alcerreca M., Gondim L.F., Ellis J.T. What is the global economic impact of Neospora caninum in cattle - the billion dollar question. Int. J. Parasitol. 2013, 43(2):133-142.
39. Rojo-Montejo S., Collantes-Fernández E., López-Pérez I., Risco-Castillo V., Prenafeta A., Ortega-Mora L.M. Evaluation of the protection conferred by a naturally attenuated Neospora caninum isolate against congenital and cerebral neosporosis in mice. Vet. Res. 2012, 43:62.
40. Schorer M., Debache K., Barna F., Monney T., Müller J., Boykin D.W., Stephens C.E., Hemphill A. Di-cationic arylimidamides act against Neospora caninum tachyzoites by interference in membrane structure and nucleolar integrity and are active against challenge infection in mice. Int. J. Parasitol. Drugs Drug Resist. 2012, 2:109-120.
41. Whitten M.K. Effects of exteroceptive factors on the oestrous cycle of mice. Nature 1957, 180(4599):1436.
42. Williams D.J., Guy C.S., Smith R.F., Ellis J., Bjorkman C., Reichel M.P., Trees A.J. Immunization of cattle with live tachyzoites of Neospora caninum confers protection against fetal death. Infect. Immun. 2007, 75(3):1343-1348.
43. Zhang H., Nishikawa Y., Yamagishi J., Zhou J., Ikehara Y., Kojima N., Yokoyama N., Xuan X. Neospora caninum: Application of apical membrane antigen 1 encapsulated in the oligomannose-coated liposomes for reduction of offspring mortality from infection in BALB/c mice. Exp. Parasitol. 2010, 125(2):130-136.